Digital Health Technologies Framework News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This is Part 1 in a series of blog posts on developments from the U.S. Food and Drug Administration (“FDA”) regarding its commitments set forth under the Prescription Drug Under Fee Act.

Reed smithSteering committeeDrug development tool qualification programDrug administrationDuke margolis centerProduct developmentDigital health technologies frameworkClinical trial diversityDrug omnibus reform actPresident bidenTrial diversityPrescription drug user fee actDigital health technologiesBiological product developmentRemote data acquisitionClinical investigations